Results 191 to 200 of about 4,746,761 (313)

Stromagenesis and cancer‐associated fibroblast heterogeneity in primary tumors and metastasis: focus in non‐small cell lung cancer

FEBS Open Bio, EarlyView.
Cancer‐associated fibroblasts (CAFs) play different roles in NSCLC progression and metastasis. Their heterogeneous origins and phenotypes shape the tumor microenvironment and influence metastatic spread. This review highlights NSCLC CAF subtypes, their potential cellular sources, and their differential distribution across primary tumors and distant ...
Alejandro Bernardo, Natalia Díaz‐Valdivia, Patricia Fernández‐Nogueira, Jordi Alcaraz   +3 more
wiley   +1 more source

Rural providers' attitudes toward integrating harm reduction strategies and PrEP prescribing into rural primary care settings in the US. Southeast and Midwest. [PDF]

Addict Sci Clin Pract
Marotta PL, Biaid M, Heimer R, Humphries D, Wang K, Narayanan N, Lynch Z, McKay V, Reno H, Winograd R, Goddard-Eckrich D, Filiatreau L, Stringer K, Backes K, Cavazos-Rehg P.   +14 more
europepmc   +1 more source

Substantial reduction of inappropriate tablet splitting with computerised decision support: a prospective intervention study assessing potential benefit and harm [PDF]

, 2009
Renate Quinzler, S. P. W. Schmitt, Maria Pritsch, Jens Kaltschmidt, Walter E. Haefeli   +4 more
openalex   +1 more source

Statins induce monocytic differentiation in acute myeloid leukemia cells through the KLF4/DPYSL2A axis

FEBS Open Bio, EarlyView.
Statins, identified via the Comparative Toxicogenomics Database, promote monocytic differentiation and apoptosis in non‐APL AML cells by upregulating DPYSL2A through a KLF4‐dependent pathway. Mevalonate supplementation reversed these effects, indicating involvement of the mevalonate pathway.
Mina Noura, Kota Shoji, Michidai Nobe, Moe Ishikawa, Miu Tanaka, Akiko Okayama, Souichi Adachi, Hidemasa Matsuo   +7 more
wiley   +1 more source

The peers expanding engagement in stimulant harm reduction with contingency management study: a protocol paper. [PDF]

Addict Sci Clin Pract
Cooke A, Stack E, Peng L, Cook R, Hartzler B, Leichtling G, Hildebran C, Leahy JM, Payne KS, Kunkel LE, Hoffman K, Korthuis PT.   +11 more
europepmc   +1 more source

Harm reduction for injecting opiate users: an update and implications in China [PDF]

, 2009
Maja Meise, Xi Wang, Marie-Luise Sauter, Yanping Bao, Jie Shi, Zhimin Liu, Lin Lü   +6 more
openalex   +1 more source

Microbial profile of the appendix niche in acute appendicitis: a novel sampling approach

FEBS Open Bio, EarlyView.
This study utilized a novel sampling method, ERAT (i.e. endoscopic retrograde appendicitis treatment)‐guided lumen aspiration, to obtain samples from the appendix, and shotgun metagenomic sequencing was performed for in situ characterization of the appendix microbiome in patients with acute appendicitis.
Huimin Ma, Mingfei Wang, Yanhu Feng, Wanqi Zhang, Wenbo Wang, Yanfeng Xie, Guixiang Kong, Jie Feng, Pengfei Wang, Qi Wang, Xiaojun Huang   +10 more
wiley   +1 more source

EXPANDED ACCESS TO SEPs AND OTHER HARM REDUCTION MEASURES IN FRANCE [PDF]

, 2009
Patrizia Carrieri, Jean‐Claude Desenclos   +1 more
openalex   +1 more source

Key role for inhibins in effective T cell activation, migration and Th17 differentiation

FEBS Open Bio, EarlyView.
Activins/inhibins modulate immune responses. Here, we show that inhibins can be produced very early after T cell activation and can act in an autocrine way, favoring Th1 versus Th17 differentiation and CCL19/CCL21 mediated migration. Recombinant inhibin A can restore the Th1/Th17 balance, highlighting the role of inhibins as key regulators of T cell ...
Sandra Ortega‐Francisco, Roxana Olguín‐Alor, Lizbeth Bolaños‐Castro, Alexandra Morales‐Cruz, Marisol De La Fuente‐Granada, Gloria Soldevila   +5 more
wiley   +1 more source

Mini-review: Harm reduction strategies among people who intentionally use fentanyl. [PDF]

Addict Behav Rep
Paredes J, Sandhu A, Huo S, Timberlake DS.   +3 more
europepmc   +1 more source